Clinical Trial Update: PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer [NA]

View source ↗

Summary

PROMOTE is a UCSF-sponsored clinical trial aiming to identify predictive markers of response in genitourinary cancers, including prostate cancer, advanced renal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Renal Cell Carcinoma
• Urothelial Carcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Cancer, Advanced Renal Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING